Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Cutting edge: proangiogenic properties of alternatively activated dendritic cellsElena Riboldi, Tiziana Musso, Emanuela Moroni, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomavirusesValeria Cagno, Manuela Donalisio, Antonella Bugatti, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2008
Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirusDavid Lembo, Manuela Donalisio, Marco Rusnati, et al.
International Journal of Molecular Sciences|April 5, 2020
Recent Strategic Advances in CFTR Drug Discovery: An OverviewMarco Rusnati, Pasqualina D'Ursi, Nicoletta Pedemonte, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2010
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomavirusesManuela Donalisio, Marco Rusnati, Andrea Civra, et al.
FEBS Letters|June 16, 2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonistsChiara Urbinati, Antonella Bugatti, Pasqua Oreste, et al.
Blood|March 20, 2004
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisMarco Rusnati, Maura Camozzi, Emanuela Moroni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivoMaura Camozzi, Serena Zacchigna, Marco Rusnati, et al.
Pageof 10